Foundation for Sarcoidosis Research (FSR) receives confirmation from the Department of Labor (DOL) ensuring patient access to FMLA for participation in clinical trials 
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal womenTVB-009P,...
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery...
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
Global study in approximately 180 adults with hidradenitis suppurativa to assess the efficacy and safety of two dose regimens of...
Diagonal Therapeutics to Present at the Cure HHT’s 15th International Scientific Conference
Diagonal is advancing its lead program to treat the underlying cause of hereditary hemorrhagic telangiectasia (HHT)WATERTOWN, Mass., Oct. 08, 2024...
KSQ Therapeutics Appoints Anna Truppel-Hartmann, M.D., as Chief Medical Officer
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for...
VitalHub Completes Acquisition of MedCurrent Corporation
TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (“VitalHub” or the “Company”) is pleased to...
Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025
Parisa Zamiri, MD, PhD, and Tom Reilly respectively appointed CMO and CFO Anand Sundaram appointed Vice President Marketing MELBOURNE, Australia...
23andMe Announces Mathew Knowles as New Brand Ambassador
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risksSUNNYVALE,...
Commencement of trading on OTCQB in the United States
Renalytix plc American Depository Shares (ADSs) begin trading on OTCQB Venture Market under symbol “RNLXY” effective from Market Open on October...
Delivra Health Brands Reports Continued Growth with Positive Adjusted EBITDA(1) and Improved Financial Results for FY2024
Delivra is a unique consumer packaged goods company strategically positioned in the health and wellness sector that provides high-quality brands...
Pop culture meets a sense of wellbeing: inspiring ToyTrends for Spielwarenmesse 2025
Two new trends: 'Anime & Friends' and 'Healthy Heroes'Perfect position: new central location at Eingang MitteNUREMBERG, Germany, Oct. 8, 2024 /PRNewswire/...
IRLAB Receives Milestone Payment of USD 2.5 million in Conjunction with First Dosing in a Phase I Study with IRL757 in Healthy Older Adults
GOTHENBURG, SWEDEN / ACCESSWIRE / October 8, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company...
Bioz is Driving the Shift to Digital Marketing, Revolutionizing the Way Product Suppliers and Distributors Connect With Researchers
PALO ALTO, CA / ACCESSWIRE / October 8, 2024 / Bioz, Inc., a leader in AI-driven research solutions that drive...
FendX To Present at the Global Markets Forum in New York City and Provides Corporate Update
Oakville, Ontario--(Newsfile Corp. - October 7, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
Nevada Transplant Institute, in Partnership With Renown Transplant Institute, Seeks Patients in Need of Kidney Transplant Surgeries
New Institute currently offering screenings, launches 1-833-RING-NTILAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / The Nevada Transplant Institute®...
Correction to Press Release Issued October 1, 2024 Regarding Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - October 7, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), announced today a correction...
Pharmaceutical Contract Research and Manufacturing Market to grow by USD 141.3Billion from 2024-2028, driven by cost-efficient resources in emerging markets, AI-powered report – Technavio
NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The Global Pharmaceutical Contract...
Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024
SAN DIEGO, Oct. 7, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the...
JOSH Revolutionizes Clinical Workflow with AI-Powered Notes for Clinical Teams
GRAND BLANC, Mich., Oct. 7, 2024 /PRNewswire/ -- ModuleMD, a leading innovator in healthcare technology for over 24 years, proudly announces the...
Otsuka Precision Health, Inc. (OPH) and Amalgam Rx Announce the Digital Support Solution for Caregivers Supporting Patients with Alzheimer’s Disease
Elevmi™ harnesses the power of artificial intelligence (AI) to empower the caregivers most affected by dementia related to Alzheimer’s Disease...